Med Page Today
JUNE 21, 2024
(MedPage Today) -- As temperatures and humidity soar outside, what's happening inside the human body can become a life-or-death battle decided by just a few degrees. The critical danger point outdoors for illness and death from relentless heat.
Science Daily - Heart Disease
JUNE 21, 2024
While previous studies suggested an association of the most common cerebral small-vessel disease with dementia risk, new research provides evidence of causal link, identifying it as a major vascular factor.
Med Page Today
JUNE 21, 2024
(MedPage Today) -- ORLANDO -- Technologic advances aren't fulfilling their promise for improving diabetes or overall health outcomes in the U.S., argued FDA Commissioner Robert Califf, MD. "We are wowing the world in technology -- much of.
DAIC
JUNE 21, 2024
milla1cf Fri, 06/21/2024 - 20:10 June 21, 2024 — UC San Francisco interventional cardiologists and interventional echocardiographers recently performed the health system’s first commercial transcatheter tricuspid valve replacement procedure using the Edwards EVOQUE system. The novel and minimally invasive cardiac procedure was recently approved for use within the U.S. by the Food and Drug Administration.
Med Page Today
JUNE 21, 2024
(MedPage Today) -- As an adjunct to bypass surgery for ischemic cardiomyopathy, a cardiac shockwave therapy aimed at regenerating ischemic myocardium boosted left ventricular ejection fraction (LVEF) and physical function at 1 year in a small sham.
DAIC
JUNE 21, 2024
milla1cf Fri, 06/21/2024 - 20:15 June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of Cardiology: Heart Failure has published a research paper concluding that INPEFA (sotagliflozin) is cost-effective for people with diabetes and recent worsening heart failure using commonly accepted willingness-to-pay thresholds.
HCPLive
JUNE 21, 2024
A first-time trial presented at ADA 2024 found the common cholesterol-lowering drug halts vision loss in patients with diabetic eye disease.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
HCPLive
JUNE 21, 2024
Tirzepatide reduces OSA severity by 30 events/hour and achieves remission in up to 51% of patients with obesity, per SURMOUNT-OSA study results from Eli Lilly and Company.
Dr. Smith's ECG Blog
JUNE 21, 2024
A patient in the ICU with significant underlying cardiac disease [HFrEF 30%, non-ischemic cardiomyopathy, LBBB s/p CRT-D (biventricular pacer), AVNRT s/p ablation a few yrs ago, hx sinus tachycardia while on max tolerated BB therapy] went into a regular wide-complex tachycardia after intubation for severe COPD exacerbation. Here is the ECG: Regular Wide Complex Tachycardia at a rate of 166 bpm.
HCPLive
JUNE 21, 2024
New phase 1/2 data suggest VX-880 islet cell therapy may restore physiological islet function and glycemic control in patients with T1D, potentially eliminating the need for insulin use.
American College of Cardiology
JUNE 21, 2024
Air pollution can greatly increase the risk of cardiovascular disease and mortality in patients with cancer and can contribute to health disparities related to both conditions,
HCPLive
JUNE 21, 2024
In retrospective, observational research at ADA 2024, real-world weight loss was linked to a reduction in the risk of obesity-related cancers.
Dr. Paddy Barrett
JUNE 21, 2024
If you have an early family history of heart disease, there are specific steps you need to take to define if you have an increased risk and what to do about it. Heart disease is the leading cause of death worldwide, and the probability of someone in your family having heart disease is likely to be high. This does not mean it was genetic. Just that heart disease is common.
HCPLive
JUNE 21, 2024
Atul Malhotra, MD, discusses the results of the SURMOUNT-OSA trial and how they inform clinicians on the role of tirzepatide in OSA and obesity.
CardiacWire
JUNE 21, 2024
Columbia and Cornell researchers developed an echo AI model that could improve the difficult task of mitral regurgitation diagnosis, and might even represent an AI-driven step towards enhancing all valvular regurgitation assessments. Transthoracic echocardiography is the go-to modality for mitral regurgitation diagnosis, but these exams are difficult to perform and prone to high variability.
HCPLive
JUNE 21, 2024
Loftus explains the significance of IL-23 and Th17 in IBD and key trial data supporting the FDA approval of risankizumab in ulcerative colitis.
American College of Cardiology
JUNE 21, 2024
What is the safety and effectiveness of P2Y12 inhibitor pretreatment in patients transferred for primary percutaneous coronary intervention (PPCI) within a regional ST-segment elevation myocardial infarction (STEMI) network?
HCPLive
JUNE 21, 2024
The incidences of adverse events were comparable between the original and current analyses of patients with moderate to severe RA treated with filgotinib.
Journal of Cardiothoracic Surgery
JUNE 21, 2024
Cor triatriatum sinister (CTS) is an uncommon congenital cardiac anomaly. Atrial fibrillation (AF) is commonly the initial symptom in patients with CTS, occurring in approximately 32% of the cases. The complex.
HCPLive
JUNE 21, 2024
Patients with the highest daily step count had a 45% lower risk of RA compared with patients in the lowest quarter (< 6818 daily steps).
Journal of Cardiothoracic Surgery
JUNE 21, 2024
Objective Systematic evaluation of the safety of del Nido cardioplegia compared to cold blood cardioplegia in adult cardiac surgery. Methods We systematically searched PubMed, EMbase, The Cochrane Library and ClinicalTrials.gov for randomized clinical trials (published by 14 January 2024) comparing del Nido cardioplegia to cold blood cardioplegia in adult.
HCPLive
JUNE 21, 2024
In this systematic review and meta-analysis, the clinical efficacy of glucagon-like peptide 1 receptor agonists was evaluated.
Journal of Cardiothoracic Surgery
JUNE 21, 2024
Esophageal cancer represents a significant public health concern; however, reliable diagnostic and prognostic markers have not been established. This study aimed to investigate the clinical value of plasma D-d.
HCPLive
JUNE 21, 2024
Focusing on evolving therapeutic paradigms for patients with COPD, experts discuss the importance of earlier diagnosis and treatment.
Journal of Cardiothoracic Surgery
JUNE 21, 2024
The question of whether segmentectomy and lobectomy have similar survival outcomes for patients with early-stage non-small cell lung cancer (NSCLC) is a matter of debate.
American College of Cardiology
JUNE 21, 2024
What is the difference in utilization of lipid management strategies when using a vascular care team including a clinical pharmacist versus usual care with provider education for patients with peripheral artery disease (PAD)?
HCPLive
JUNE 21, 2024
Although AAT therapy was found to be well-tolerable, the infusions did not improve C-peptide AUC in patients with chronic pancreatitis undergoing TP-IAT.
American College of Cardiology
JUNE 21, 2024
To what extent does left ventricular ejection fraction (LVEF) improve beyond 90 days in patients with de novo heart failure with reduced ejection fraction (HFrEF)?
HCPLive
JUNE 21, 2024
The panel concludes its discussion by talking about resources available for providers in managing their patients with HIV who experience drug resistance.
Journal of Cardiothoracic Surgery
JUNE 21, 2024
A left thoracotomy approach is anatomically appropriate for childhood aortic coarctation; however, the pediatric femoral arteriovenous diameters are too small for cardiopulmonary bypass cannulation. We aimed t.
HCPLive
JUNE 21, 2024
Phase 2 data showed a significant reduction in RA disease activity at Week 12 with weekly abiprubart, compared with placebo.
Journal of the American Heart Association
JUNE 21, 2024
Journal of the American Heart Association, Ahead of Print.
HCPLive
JUNE 21, 2024
Experts on HIV offer insights into switching therapies for patients with a history of resistance, highlighting ways to simplify and optimize treatment.
Physiologically Speaking
JUNE 21, 2024
Greetings! Welcome to the Physiology Friday newsletter. Details about the sponsors of this newsletter including Examine.com and my book “VO2 Max Essentials ” can be found at the end of the post! Physiologically Speaking is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
HCPLive
JUNE 21, 2024
A study presented at EULAR 2024 found tender joint count was linked to depression and illness perception but not anxiety.
HCPLive
JUNE 21, 2024
Clinical insights on the relationship between comorbidities in COPD and how multimorbidity plays a role in treatment decisions.
HCPLive
JUNE 21, 2024
Phase 3 data showed patients treated with SHR0302 4 mg or 8 mg had greater improvements in ACR20 response rates and other key secondary outcomes versus placebo.
Expert insights. Personalized for you.
127 
Let's personalize your content